Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Sildenafil in Neonates with PPHN
NCT01720524Phase 3Completed
- Sponsor
- Viatris
- Start
- Aug 2013
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of sildenafil in persistent pulmonary hypertension of the newborn (PPHN), sponsored by Viatris. Started Aug 2013; status: completed.
02
Drugs
sildenafil
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on NCT01720524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01720524.